Investigational drug · Phase 2
AC102
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Hearing Loss, Sensorineural.
Phase 2Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
1
Any phase or sponsor naming "AC102"
First trial start
2022
Oct 13, 2022
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "AC102", any sponsor or status.
Conditions studied
As listed on its trial records.
- Hearing Loss, Sensorineural
Largest trials
Live from ClinicalTrials.gov: studies naming "AC102" as an intervention, largest first.
- Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)Pivotal-lookingCompleted
AudioCure Pharma GmbHIndustry
NCT05776459 · 223 participants · Start Oct 13, 2022 · Primary completion Nov 18, 2025
Drug: AC102 gel; Prednisolone · For: Hearing Loss, Sensorineural
Sites: Graz, Austria; Linz, Austria; Salzburg, Austria · 39 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Assessment of Safety, Tolerability, Pharmacokinetics, and Volume-Dependent Conductive Hearing Loss in Healthy Volunteers: First-in-Human, Open-Label, Placebo-Controlled Study of a Single Intratympanic Injection of AC102.
Lanting C, Robijn S, Nieratschker M, et al. · Otol Neurotol 2025
- A Single Dose of AC102 Reverts Tinnitus by Restoring Ribbon Synapses in Noise-Exposed Mongolian Gerbils.
Tziridis K, Rasheed J, Kwiatkowska M, et al. · Int J Mol Sci 2025
- Silicone-based AC102-loaded cochlear implant coatings protect residual hearing in an animal model of cochlear implantation.
Nieratschker M, Mistrik P, Petrasek Z, et al. · Hear Res 2024
- A preoperative dose of the pyridoindole AC102 improves the recovery of residual hearing in a gerbil animal model of cochlear implantation.
Nieratschker M, Yildiz E, Gerlitz M, et al. · Cell Death Dis 2024
- A single dose of AC102 restores hearing in a guinea pig model of noise-induced hearing loss to almost prenoise levels.
Rommelspacher H, Bera S, Brommer B, et al. · Proc Natl Acad Sci U S A 2024
- Effects of CRM1-dependent nuclear export inhibition on viral structural protein nuclear accumulation during Autographa californica multiple nucleopolyhedrovirus infection.
Hu X, Tian L, Li J, et al. · Virus Res 2021
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.